Surface-induced crystallization of pharmaceuticals and biopharmaceuticals: A review.
Identifieur interne : 000057 ( Main/Curation ); précédent : 000056; suivant : 000058Surface-induced crystallization of pharmaceuticals and biopharmaceuticals: A review.
Auteurs : Fiora Artusio [Italie] ; Roberto Pisano [Italie]Source :
- International journal of pharmaceutics [ 1873-3476 ] ; 2018.
Descripteurs français
- KwdFr :
- MESH :
- composition chimique : Préparations pharmaceutiques.
- Cristallisation, Propriétés de surface.
English descriptors
- KwdEn :
- MESH :
- chemical , chemistry : Pharmaceutical Preparations.
- Crystallization, Surface Properties.
Abstract
Despite the wide occurrence of crystallization in the pharmaceutical industry, deep understanding and fine control of the process remain a tricky issue. Nevertheless, the successful manufacturing of finished pharmaceutical products, as well as the structural determination of biopharmaceuticals, depend on the size, form, shape and purity of the crystals. The ability of substrates with precise chemistry and topological features to induce nucleation has been thoroughly assessed during the recent years. This paper reviews the major advances and discoveries in controlling small molecule drug and protein crystallization by means of engineered surfaces. By designing superficial properties and morphology, it has been possible to tune the polymorph outcome, shorten the nucleation induction time, impose specific crystal shapes, control the crystal size and carry out crystallization at very low supersaturation levels. Such achievements underline the potential of surface-induced crystallization to provide an ideal platform for the study of the nucleation process and gain control over its stochastic nature.
DOI: 10.1016/j.ijpharm.2018.05.069
PubMed: 29859921
Links toward previous steps (curation, corpus...)
- to stream Main, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000057
Links to Exploration step
pubmed:29859921Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Surface-induced crystallization of pharmaceuticals and biopharmaceuticals: A review.</title><author><name sortKey="Artusio, Fiora" sort="Artusio, Fiora" uniqKey="Artusio F" first="Fiora" last="Artusio">Fiora Artusio</name><affiliation wicri:level="1"><nlm:affiliation>Department of Applied Science and Technology, Politecnico di Torino, 24 corso Duca degli Abruzzi, Torino 10129, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Applied Science and Technology, Politecnico di Torino, 24 corso Duca degli Abruzzi, Torino 10129</wicri:regionArea></affiliation></author><author><name sortKey="Pisano, Roberto" sort="Pisano, Roberto" uniqKey="Pisano R" first="Roberto" last="Pisano">Roberto Pisano</name><affiliation wicri:level="1"><nlm:affiliation>Department of Applied Science and Technology, Politecnico di Torino, 24 corso Duca degli Abruzzi, Torino 10129, Italy. Electronic address: roberto.pisano@polito.it.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Applied Science and Technology, Politecnico di Torino, 24 corso Duca degli Abruzzi, Torino 10129</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2018">2018</date><idno type="RBID">pubmed:29859921</idno><idno type="pmid">29859921</idno><idno type="doi">10.1016/j.ijpharm.2018.05.069</idno><idno type="wicri:Area/Main/Corpus">000057</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000057</idno><idno type="wicri:Area/Main/Curation">000057</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000057</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Surface-induced crystallization of pharmaceuticals and biopharmaceuticals: A review.</title><author><name sortKey="Artusio, Fiora" sort="Artusio, Fiora" uniqKey="Artusio F" first="Fiora" last="Artusio">Fiora Artusio</name><affiliation wicri:level="1"><nlm:affiliation>Department of Applied Science and Technology, Politecnico di Torino, 24 corso Duca degli Abruzzi, Torino 10129, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Applied Science and Technology, Politecnico di Torino, 24 corso Duca degli Abruzzi, Torino 10129</wicri:regionArea></affiliation></author><author><name sortKey="Pisano, Roberto" sort="Pisano, Roberto" uniqKey="Pisano R" first="Roberto" last="Pisano">Roberto Pisano</name><affiliation wicri:level="1"><nlm:affiliation>Department of Applied Science and Technology, Politecnico di Torino, 24 corso Duca degli Abruzzi, Torino 10129, Italy. Electronic address: roberto.pisano@polito.it.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Applied Science and Technology, Politecnico di Torino, 24 corso Duca degli Abruzzi, Torino 10129</wicri:regionArea></affiliation></author></analytic><series><title level="j">International journal of pharmaceutics</title><idno type="eISSN">1873-3476</idno><imprint><date when="2018" type="published">2018</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Crystallization (MeSH)</term><term>Pharmaceutical Preparations (chemistry)</term><term>Surface Properties (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Cristallisation (MeSH)</term><term>Propriétés de surface (MeSH)</term><term>Préparations pharmaceutiques (composition chimique)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en"><term>Pharmaceutical Preparations</term></keywords><keywords scheme="MESH" qualifier="composition chimique" xml:lang="fr"><term>Préparations pharmaceutiques</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Crystallization</term><term>Surface Properties</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Cristallisation</term><term>Propriétés de surface</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Despite the wide occurrence of crystallization in the pharmaceutical industry, deep understanding and fine control of the process remain a tricky issue. Nevertheless, the successful manufacturing of finished pharmaceutical products, as well as the structural determination of biopharmaceuticals, depend on the size, form, shape and purity of the crystals. The ability of substrates with precise chemistry and topological features to induce nucleation has been thoroughly assessed during the recent years. This paper reviews the major advances and discoveries in controlling small molecule drug and protein crystallization by means of engineered surfaces. By designing superficial properties and morphology, it has been possible to tune the polymorph outcome, shorten the nucleation induction time, impose specific crystal shapes, control the crystal size and carry out crystallization at very low supersaturation levels. Such achievements underline the potential of surface-induced crystallization to provide an ideal platform for the study of the nucleation process and gain control over its stochastic nature.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29859921</PMID><DateCompleted><Year>2018</Year><Month>10</Month><Day>15</Day></DateCompleted><DateRevised><Year>2018</Year><Month>10</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-3476</ISSN><JournalIssue CitedMedium="Internet"><Volume>547</Volume><Issue>1-2</Issue><PubDate><Year>2018</Year><Month>Aug</Month><Day>25</Day></PubDate></JournalIssue><Title>International journal of pharmaceutics</Title><ISOAbbreviation>Int J Pharm</ISOAbbreviation></Journal><ArticleTitle>Surface-induced crystallization of pharmaceuticals and biopharmaceuticals: A review.</ArticleTitle><Pagination><MedlinePgn>190-208</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0378-5173(18)30383-1</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijpharm.2018.05.069</ELocationID><Abstract><AbstractText>Despite the wide occurrence of crystallization in the pharmaceutical industry, deep understanding and fine control of the process remain a tricky issue. Nevertheless, the successful manufacturing of finished pharmaceutical products, as well as the structural determination of biopharmaceuticals, depend on the size, form, shape and purity of the crystals. The ability of substrates with precise chemistry and topological features to induce nucleation has been thoroughly assessed during the recent years. This paper reviews the major advances and discoveries in controlling small molecule drug and protein crystallization by means of engineered surfaces. By designing superficial properties and morphology, it has been possible to tune the polymorph outcome, shorten the nucleation induction time, impose specific crystal shapes, control the crystal size and carry out crystallization at very low supersaturation levels. Such achievements underline the potential of surface-induced crystallization to provide an ideal platform for the study of the nucleation process and gain control over its stochastic nature.</AbstractText><CopyrightInformation>Copyright © 2018 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Artusio</LastName><ForeName>Fiora</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Applied Science and Technology, Politecnico di Torino, 24 corso Duca degli Abruzzi, Torino 10129, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pisano</LastName><ForeName>Roberto</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Applied Science and Technology, Politecnico di Torino, 24 corso Duca degli Abruzzi, Torino 10129, Italy. Electronic address: roberto.pisano@polito.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>05</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Int J Pharm</MedlineTA><NlmUniqueID>7804127</NlmUniqueID><ISSNLinking>0378-5173</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004364">Pharmaceutical Preparations</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D003460" MajorTopicYN="N">Crystallization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004364" MajorTopicYN="N">Pharmaceutical Preparations</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013499" MajorTopicYN="N">Surface Properties</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">5-Methyl-2-[(2-nitrophenyl)amino]-3-thiophenecarbonitrile</Keyword><Keyword MajorTopicYN="N">Acetaminophen</Keyword><Keyword MajorTopicYN="N">Active pharmaceutical ingredient (API)</Keyword><Keyword MajorTopicYN="N">Aspirin</Keyword><Keyword MajorTopicYN="N">Carbamazepine</Keyword><Keyword MajorTopicYN="N">Catalase</Keyword><Keyword MajorTopicYN="N">Crystallization</Keyword><Keyword MajorTopicYN="N">Engineered surfaces</Keyword><Keyword MajorTopicYN="N">Glycine</Keyword><Keyword MajorTopicYN="N">Heterogeneous nucleation</Keyword><Keyword MajorTopicYN="N">Indomethacin</Keyword><Keyword MajorTopicYN="N">Lysozyme</Keyword><Keyword MajorTopicYN="N">Protein</Keyword><Keyword MajorTopicYN="N">Small molecule drug</Keyword><Keyword MajorTopicYN="N">Thaumatin</Keyword><Keyword MajorTopicYN="N">Trypsin</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>03</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>05</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>05</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>6</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>10</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>6</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29859921</ArticleId><ArticleId IdType="pii">S0378-5173(18)30383-1</ArticleId><ArticleId IdType="doi">10.1016/j.ijpharm.2018.05.069</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Bois/explor/ThaumatinV1/Data/Main/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000057 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 000057 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Bois
|area= ThaumatinV1
|flux= Main
|étape= Curation
|type= RBID
|clé= pubmed:29859921
|texte= Surface-induced crystallization of pharmaceuticals and biopharmaceuticals: A review.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/RBID.i -Sk "pubmed:29859921" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Curation/biblio.hfd \
| NlmPubMed2Wicri -a ThaumatinV1
| This area was generated with Dilib version V0.6.37. |  |